Non-small cell lung carcinoma of the superior sulcus: Favourable outcomes of combined modality treatment in carefully selected patients

Lung Cancer

Volumn 59, Issue 3, 2008, Pages 385-390

  Kappers, I ^a   Belderbos, J S A ^a   Burgers, J A ^a   van Zandwijk, N ^a   Groen, H J M ^b   Klomp, H M ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Combined modality treatment; Neoadjuvant treatment; Non small cell lung carcinoma; Pancoast tumours; Superior sulcus tumours

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DYSPHAGIA; FEMALE; HUMAN; LOW DRUG DOSE; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCOAST TUMOR; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PATIENT SELECTION; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SPINAL NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 40249088320     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.08.028     Document Type: Article

References (28)

1. Pancoast H.K. Superior pulmonary sulcus tumors. JAMA 99 (1932) 1391-1396
2. Dartevelle P., and Macchiarini P. Surgical management of superior sulcus tumors. Oncologist 4 (1999) 398-407
3. Detterbeck F.C. Changes in the treatment of Pancoast tumors. Ann Thorac Surg 75 (2003) 1990-1997
4. Rusch V.W., Giroux D.J., Kraut M.J., Crowley J., Hazuka M., Winton T., et al. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest oncology group trial 9416 (intergroup trial 0160). J Clin Oncol 25 (2007) 313-318
5. Voltolini L., Rapicetta C., Luzzi L., Ghiribelli C., Ligabue T., Paladini P., et al. Lung cancer with chest wall involvement: predictive factors of long-term survival after surgical resection. Lung Cancer 52 (2006) 359-364
6. Shaw R.R., Paulson D.L., and Kee Jr. J.L. Treatment of the superior sulcus tumor by irradiation followed by resection. Ann Surg 154 1 (1961) 29-40
7. Sonett J.R., Suntharalingam M., Edelman M.J., Patel A.B., Gamliel Z., Doyle A., et al. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer. Ann Thorac Surg 78 (2004) 1200-1205
8. Wright C.D., Menard M.T., Wain J.C., Donahue D.M., Grillo H.C., Lynch T.J., et al. Induction chemoradiation compared with induction radiation for lung cancer involving the superior sulcus. Ann Thorac Surg 73 (2002) 1541-1544
9. Birim O., Maat A.P., Kappetein A.P., van Meerbeeck J.P., Damhuis R.A., and Bogers A.J. Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer. Eur J Cardiothorac Surg 23 (2003) 30-34
10. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
11. Belderbos J., Uitterhoeve L., van Zandwijk N., Belderbos H., Rodrigus P., van de Vaart P., et al. Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973). Eur J Cancer 43 (2007) 114-121
12. Uitterhoeve A.L., Belderbos J.S., Koolen M.G., van der Vaart P.J., Rodrigus P.T., Benraadt J., et al. Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I/II study. European organization for research and treatment of cancer. Eur J Cancer 36 (2000) 592-600
13. Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S., Rubinstein L., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 (2000) 205-216
14. Belderbos J.S., Heemsbergen W.D., De Jaeger K., Baas P., and Lebesque J.V. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) 126-134
15. Hilaris B.S., Martini N., Wong G.Y., and Nori D. Treatment of superior sulcus tumor (Pancoast tumor). Surg Clin North Am 67 (1987) 965-977
16. Paulson D.L. The survival rate in superior sulcus tumors treated by presurgical irradiation. JAMA 196 (1966) 342
17. Millar J., Ball D., Worotniuk V., Smith J., Crennan E., and Bishop M. Radiation treatment of superior sulcus lung carcinoma. Australas Radiol 40 (1996) 55-60
18. Neal C.R., Amdur R.J., Mendenhall W.M., Knauf D.G., Block A.J., and Million R.R. Pancoast tumor: radiation therapy alone versus preoperative radiation therapy and surgery. Int J Radiat Oncol Biol Phys 21 (1991) 651-660
19. Albain K.S., Crowley J.J., Turrisi III A.T., Gandara D.R., Farrar W.B., Clark J.I., et al. Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a southwest oncology group phase II study, SWOG 9019. J Clin Oncol 20 (2002) 3454-3460
20. Fadel E., Missenard G., Chapelier A., Mussot S., Leroy-Ladurie F., Cerrina J., et al. En bloc resection of non-small cell lung cancer invading the thoracic inlet and intervertebral foramina. J Thorac Cardiovasc Surg 123 (2002) 676-685
21. Gandhi S., Walsh G.L., Komaki R., Gokaslan Z.L., Nesbitt J.C., Putnam Jr. J.B., et al. A multidisciplinary surgical approach to superior sulcus tumors with vertebral invasion. Ann Thorac Surg 68 (1999) 1778-1784
22. Grunenwald D.H., Mazel C., Girard P., Veronesi G., Spaggiari L., Gossot D., et al. Radical en bloc resection for lung cancer invading the spine. J Thorac Cardiovasc Surg 123 (2002) 271-279
23. Kunitoh H. A phase II trial of pre-operative chemoradiotherapy followed by surgical resection in Pancoast tumors: initial report of Japanese clinical oncology group trial (JCOG 9806). Proc Am Soc Clin Oncol 22 (2003) 2549a
24. Paulson D.L. The importance of defining location and staging of superior pulmonary sulcus tumors. Ann Thorac Surg 15 (1973) 549-551
25. Arriagada R., Bergman B., Dunant A., Le Chevalier T., Pignon J.P., and Vansteenkiste J. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350 (2004) 351-360
26. Erman M., Moretti L., Soria J.C., Le Chevalier T., and Van Houtte P. Adjuvant chemotherapy and radiotherapy in non-small cell lung cancer. Semin Radiat Oncol 14 (2004) 315-321
27. Strauss G.A. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): report of cancer and leukemia group B (CALGB) protocol 9633. ASCO Annual Meeting Proceedings (Post-meeting Edition), vol. 22, No. 14S (2004) [Abstract 7019]
28. Winton T.L. A prospective randomised trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage 1B and II non small cell lung cancer (NSCLC) intergroup JBR. 10. ASCO Annual Meeting Proceeding (2004) [Abstract 7018]